BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

NOVEMBER 2005

Epitan Announces New Funding of $10 million and Restructures Management to Address Global Opportunity of EPT 1647

Apollo Enters US$400 million R&D reagents market with unique human proteins

Capsulution Nanoscience AG - Further Fundamental Patent Grant is Imminent

Macrozyme Announces a Collaboration with Genzyme Corporation in Diabetes and Other Possible Indications

OXFORD BIOMEDICA RECEIVES NOTICE OF PATENT ALLOWANCE EXTENDING TROVAX® PROTECTION IN THE UNITED STATES

East Midlands' bioscience knowledge exchange initiative launched

Immutep Initiates Phase I Clinical Trial in Renal Cell Cancer

MNLPHARMA RECEIVES £700K (EUR 1 MILLION) AWARD FROM THE WELSH DEVELOPMENT AGENCY FOR PRECLINICAL DEVELOPMENT OF ITS NOVEL CANCER IMMUNOTHERAPEUT

Roche scales up Tamiflu production

Lab21 FibroTest-ActiTest – the alternative to liver biopsy

SCIpharm 2006 – poster submissions closing

Lab21 team strengthened by new appointment

Lab21 FibroTest-ActiTest – the alternative to liver biopsy

INTEGRAGEN COMPLETES Euro 8 MILLION FINANCING TO PROGRESS GENETIC TESTS FOR COMPLEX DISEASES, INCLUDING AUTISM AND METABOLIC SYNDROME

GeneFlash Gel Documentation System Is Used in New Study on Microbial causes of Childhood Asthma

OXFORD BIOMEDICA COMMENCES SECOND PHASE II TRIAL WITH TROVAX® IN RENAL CELL CARCINOMA

Cobra further strengthens management team

CLC Protein Workbench: The next generation of protein informatics

Dow Pharmaceutical Sciences Receives FDA Approval of NDA for Galderma’s Clobex® Spray for Moderate-to-Severe Plaque Psoriasis

SOLEXA REPORTS THIRD QUARTER FINANCIAL RESULTS

BioInvent and Lund University present data on significant plaque reduction in blood vessels

Competition is needed in the follicle stimulating hormone (FSH) market

Herpes and respiratory antivirals: Avaian flu catalyst for maintaining market growth

Glucon's Aprise, a Continuous, Non-invasive Glucose Monitoring Device, Shows Positive Clinical Results

OXFORD BIOMEDICA'S INNUREX® NERVE REGENERATION PROGRAMME HIGHLIGHTED DURING BRIEFING FOR £30 MILLION LINK PROGRAMME

European biotech industry debates new Advanced Therapies Regulation together with all stakeholders

SOLEXA STRENGTHENS PATENT POSITION IN NEXT-GENERATION GENETIC ANALYSIS

Sigma-Aldrich Names Jai Nagarkatti Chief Executive Officer Effective January 1, 2006

Powdermed’s PMED “GENE Gun” NAMED TO THE POPULAR SCIENCE®

Hybrigenics names new CEO and board chairman

FDA approves IND for SPC2996 in Chronic Lymphocytic Leukaemia (CLL)

SkyePharma: hope worth sharing?

Pharma companies in R&D battle as warfarin goes on

KEY INDUSTRY SECTORS SIGN UP TO FURTHER REFINE, REDUCE AND REPLACE THE USE OF ANIMALS IN TESTING

Borean Pharma - Launch New website

Minakem and LibraGen form Strategic Alliance in Biocatalysis and Fine Chemicals Production

Cobra Biomanufacturing PLC and Advaxis, Inc enter a Strategic Collaboration and Long-Term Vaccine Supply Agreement for Listeria Cancer Vaccines

Oxford Immunotec Wins Medical Futures Innovation Award

Major Spanish Pharmaceutical Company choose IDBS to improve drug discovery

DNAVISION Has Been Chosen By Roche Diagnostics Belgium As Official Service Provider For Amplichiptm Cyp450 Testing

Oxford Biomedica Announces Progress With Registration Plan And Partnership Discussions For Trovax, Proposed Institutional Placing And Open Offer Alongside Investment By Sigma-Aldrich

CellCentric initiates new collaboration to accelerate its cancer drug discovery programme

SOLEXA TO PRESENT AT RODMAN AND RENSHAW TECHVEST 7TH ANNUAL HEALTHCARE CONFERENCE

Thrombolytic therapy needs innovation

SOLEXA TO CONDUCT TECHNOLOGY SEMINAR AT THE AMERICAN SOCIETY OF HUMAN GENETICS CONFERENCE

Sigma-Aldrich Strengthens Position in RNAi Through Licensing and Equity Positions in Benitec and Oxford BioMedica

Expert line up at SCIpharm 2006

Minster Pharmaceuticals plc: Annual General Meeting (AGM) statement

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ June 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

Site Map - new news site

Site Map - old news site
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.